Abiomed Increases Revenues by 19% to $27.2 Million and Achieves Non-GAAP Profitability While Generating $5 Million in Cash for Third Quarter of Fiscal 2011

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2011 revenue of $27.2 million, up 19% compared to the same period of fiscal 2010.